3 ms·
Sell it to me. What do you have to offer that say, Counsyl doesn't? Direct to consumer sales are dead/dying at the hands of the FDA. Gene patents look like the
by bhickey 16y ago
Sell it to me. What do you have to offer that say, Counsyl doesn't?
Direct to consumer sales are dead/dying at the hands of the FDA.
Gene patents look like they're getting legally thornier. So, what's your angle?
How do you avoid a war to the realm of being a commodity?
- checkoutmygenes 16y ago> Direct to consumer sales are dead/dying at the hands of the FDA. Not true - such rumors have been greatly exaggerated. >What do you have to offer that say, Counsyl doesn't? At the moment: Access to your whole genotype and a curated set of the published literature, rather than a narrow carrier screening. Deep ancestry analysis & finding long-lost cousins. A commitment to advancing the science of genetics. As the database grows, the insights we generate create more value for the end-user. http://tinyurl.com/246mw46 http://tinyurl.com/246mw46 In the future: There's lots of opportunity - come talk to us about it. >How do you avoid a war to the realm of being a commodity? genotyping is becoming commoditized, the interpretation of the A's, C's, G's and T's is not. We're in a sweet spot where rapidly falling costs: - let us offer our service at a lower cost to a broader market - improve the rates of discovery & create a more valuable interpretation We have an economy of scale which will allow us to: - negotiate lower costs - have a bigger database of potential relatives to meet - better interpret the meaning individual's genetics